Franklin Covey Guides FY2027 Revenue to $263M-$273M After Flat FY2026
FC sits 55% above its 52-week low of $11.16.
Summary
Q4 revenue came in at $70.0 million, down from $71.2 million a year earlier but inside the company's updated guidance range, while Q4 net income jumped to $7.1 million, or $0.62 per diluted share, from $4.4 million, or $0.34. Adjusted EBITDA rose 9% to $12.8 million despite the lower top line, helped by a $6.7 million full-year restructuring charge already absorbed. Full-year revenue fell 2.1% to $261.5 million and Adjusted EBITDA was essentially flat at $28.9 million, but Enterprise North America invoiced amounts grew 4% to $151.4 million and deferred revenue there rose 17% to $59.2 million — the backlog management is pointing to as the bridge into FY2027. Guidance calls for revenue of $263 million to $273 million and Adjusted EBITDA of $29 million to $34 million, with the China direct-office-to-licensee transition trimming about $2.0 million of reported revenue and no material EBITDA effect. Cash is the soft spot: cash and equivalents fell to $13.3 million from $31.7 million a year ago after $28.1 million of buybacks, and free cash flow dropped to $9.2 million from $12.1 million. The 5:00 p.m. ET call is where management will have to defend the FY2027 growth case.
At the time of this announcement, FC was trading at $17.33 on NYSE in the Trade & Services sector, with a market capitalization of approximately $195.7M. The 52-week trading range was $11.16 to $26.81. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.